S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:AGEN

Agenus News Headlines

$3.16
-0.23 (-6.78 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.07
Now: $3.16
$3.46
50-Day Range
$3.19
MA: $4.12
$5.25
52-Week Range
$1.82
Now: $3.16
$5.95
Volume4.61 million shs
Average Volume3.20 million shs
Market Capitalization$600.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Agenus (NASDAQ AGEN) News Headlines Today

Source:
SourceHeadline
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report - Yahoo FinanceAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report - Yahoo Finance
finance.yahoo.com - March 3 at 7:59 PM
Agenus (NASDAQ:AGEN) Stock Price Down 7.6%Agenus (NASDAQ:AGEN) Stock Price Down 7.6%
americanbankingnews.com - March 2 at 8:48 PM
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report - GlobeNewswireAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report - GlobeNewswire
globenewswire.com - March 2 at 1:30 PM
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial ReportAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
finance.yahoo.com - March 2 at 1:30 PM
Zacks: Brokerages Expect Agenus Inc. (NASDAQ:AGEN) Will Post Quarterly Sales of $16.23 MillionZacks: Brokerages Expect Agenus Inc. (NASDAQ:AGEN) Will Post Quarterly Sales of $16.23 Million
americanbankingnews.com - February 25 at 1:34 AM
Contrasting Agenus (NASDAQ:AGEN) and Vaxcyte (NASDAQ:PCVX)Contrasting Agenus (NASDAQ:AGEN) and Vaxcyte (NASDAQ:PCVX)
americanbankingnews.com - February 12 at 4:24 PM
Agenus (NASDAQ:AGEN) Trading Down 8.4%Agenus (NASDAQ:AGEN) Trading Down 8.4%
americanbankingnews.com - February 11 at 9:00 PM
Strong Buy: Agenus iNKT Cell-Therapy Extubated 3 Of First 4 Severe COVID-19 Patients In P1 Trial - Seeking AlphaStrong Buy: Agenus' iNKT Cell-Therapy Extubated 3 Of First 4 Severe COVID-19 Patients In P1 Trial - Seeking Alpha
seekingalpha.com - February 10 at 12:18 PM
Agenus names new chief commercial officer - Seeking AlphaAgenus names new chief commercial officer - Seeking Alpha
seekingalpha.com - February 10 at 2:16 AM
Agenus Announces New Responses for AGEN1181 - Yahoo FinanceAgenus Announces New Responses for AGEN1181 - Yahoo Finance
finance.yahoo.com - February 9 at 9:15 PM
Andy Hurley Named Agenus Chief Commercial Officer - GlobeNewswireAndy Hurley Named Agenus Chief Commercial Officer - GlobeNewswire
globenewswire.com - February 9 at 9:15 PM
Andy Hurley Named Agenus Chief Commercial OfficerAndy Hurley Named Agenus Chief Commercial Officer
finance.yahoo.com - February 9 at 9:15 PM
Agenus Announces Agenus Insights - Virtual R&D Miniseries - Yahoo FinanceAgenus Announces Agenus Insights - Virtual R&D Miniseries - Yahoo Finance
finance.yahoo.com - February 9 at 4:14 PM
Agenus Announces Agenus Insights - Virtual R&D Miniseries Nasdaq:AGEN - GlobeNewswireAgenus Announces Agenus Insights - Virtual R&D Miniseries Nasdaq:AGEN - GlobeNewswire
globenewswire.com - February 9 at 11:14 AM
Agenus Announces New Responses for AGEN1181Agenus Announces New Responses for AGEN1181
finance.yahoo.com - February 9 at 11:13 AM
Agenus Announces Agenus Insights - Virtual R&D MiniseriesAgenus Announces Agenus Insights - Virtual R&D Miniseries
finance.yahoo.com - February 9 at 11:13 AM
Jon Najarian Sees Unusual Option Activity In JetBlue Airways, Agenus - BenzingaJon Najarian Sees Unusual Option Activity In JetBlue Airways, Agenus - Benzinga
benzinga.com - February 4 at 8:18 PM
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 - Yahoo FinanceAgenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 - Yahoo Finance
finance.yahoo.com - February 4 at 3:18 PM
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 - GlobeNewswireAgenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 - GlobeNewswire
globenewswire.com - February 4 at 9:20 AM
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
finance.yahoo.com - February 4 at 9:20 AM
The Only Play On Agenus - Seeking AlphaThe Only Play On Agenus - Seeking Alpha
seekingalpha.com - January 26 at 11:52 PM
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - Yahoo FinanceAgenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - Yahoo Finance
finance.yahoo.com - January 26 at 11:52 PM
Agenus Says Enters Into Collaboration With Nelum For Zalifrelimab CombinationAgenus Says Enters Into Collaboration With Nelum For Zalifrelimab Combination
benzinga.com - January 26 at 6:52 PM
The Only Play On AgenusThe Only Play On Agenus
seekingalpha.com - January 26 at 4:19 PM
Agenus (AGEN) Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - StreetInsider.comAgenus (AGEN) Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - StreetInsider.com
streetinsider.com - January 26 at 1:51 PM
Agenus partners with Nelum for zalifrelimab in pancreatic cancer - Seeking AlphaAgenus partners with Nelum for zalifrelimab in pancreatic cancer - Seeking Alpha
seekingalpha.com - January 26 at 1:51 PM
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - GlobeNewswireAgenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination - GlobeNewswire
globenewswire.com - January 26 at 1:51 PM
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab CombinationAgenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
finance.yahoo.com - January 26 at 8:51 AM
Agenus to Participate in B. Riley Securities Oncology Investor Conference - Yahoo FinanceAgenus to Participate in B. Riley Securities' Oncology Investor Conference - Yahoo Finance
finance.yahoo.com - January 20 at 3:22 AM
Atea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications - StreetInsider.comAtea Pharmaceuticals Expands Senior Management Team with Key Additions in Regulatory Affairs and Investor Relations and Corporate Communications - StreetInsider.com
streetinsider.com - January 19 at 4:18 PM
Agenus to Participate in B. Riley Securities Oncology Investor Conference - GlobeNewswireAgenus to Participate in B. Riley Securities' Oncology Investor Conference - GlobeNewswire
globenewswire.com - January 19 at 4:18 PM
Agenus to Participate in B. Riley Securities Oncology Investor ConferenceAgenus to Participate in B. Riley Securities' Oncology Investor Conference
finance.yahoo.com - January 19 at 4:18 PM
AVECTAS Appoints Daniel Castro as Chief Business Officer - PRNewswireAVECTAS Appoints Daniel Castro as Chief Business Officer - PRNewswire
prnewswire.com - January 11 at 9:03 AM
BTIG Expands Healthcare Research Coverage with Biotechnology Analyst Justin Zelin - StreetInsider.comBTIG Expands Healthcare Research Coverage with Biotechnology Analyst Justin Zelin - StreetInsider.com
streetinsider.com - January 11 at 9:03 AM
XOMA: A Royalty Aggregator To Watch - Seeking AlphaXOMA: A Royalty Aggregator To Watch - Seeking Alpha
seekingalpha.com - January 4 at 6:27 PM
Is AGEN A Good Stock To Buy Now? - Yahoo FinanceIs AGEN A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 14 at 9:25 AM
Is AGEN A Good Stock To Buy Now?Is AGEN A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:25 AM
Agenus extends timeline for U.S. balstilimab application after two late responders identified - Seeking AlphaAgenus extends timeline for U.S. balstilimab application after two late responders identified - Seeking Alpha
seekingalpha.com - December 3 at 11:21 PM
Completion of Balstilimab BLA Filing Extended To 1H2021Completion of Balstilimab BLA Filing Extended To 1H2021
finance.yahoo.com - December 3 at 6:20 PM
Agenus shares are trading higher after the company launched its Phase 2 trial expansion in colon cancer for AGEN1181 in combination with Balstilimab.Agenus shares are trading higher after the company launched its Phase 2 trial expansion in colon cancer for AGEN1181 in combination with Balstilimab.
benzinga.com - December 3 at 7:34 AM
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab - GlobeNewswireAgenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab - GlobeNewswire
globenewswire.com - December 1 at 5:40 PM
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with BalstilimabAgenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
finance.yahoo.com - December 1 at 5:40 PM
Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference - GlobeNewswireAgenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference - GlobeNewswire
globenewswire.com - November 25 at 5:34 PM
Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference - GlobeNewswireAgenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference - GlobeNewswire
globenewswire.com - November 16 at 7:14 PM
Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare ConferenceAgenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
finance.yahoo.com - November 16 at 7:14 PM
Agenus: A Buy With iNKT Therapy, MK-4830 Milestone - Seeking AlphaAgenus: A Buy With iNKT Therapy, MK-4830 Milestone - Seeking Alpha
seekingalpha.com - November 15 at 2:00 PM
Agenus and Dr. Steven ODay to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC DataAgenus and Dr. Steven O'Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
marketwatch.com - November 15 at 9:00 AM
Agenus: A Buy With iNKT Therapy, MK-4830 MilestoneAgenus: A Buy With iNKT Therapy, MK-4830 Milestone
seekingalpha.com - November 13 at 11:58 PM
Agenus and Dr. Steven ODay to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - GlobeNewswireAgenus and Dr. Steven O'Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - GlobeNewswire
globenewswire.com - November 13 at 5:39 PM
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC DataAgenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
finance.yahoo.com - November 13 at 5:39 PM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.